Data Insights

ACTUS-101 by Asklepios BioPharmaceutical for Pompe Disease: Likelihood of Approval

ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - ACTUS-101 in Pompe Disease

Data Insights

AB-1005 by Asklepios BioPharmaceutical for Parkinson's Disease: Likelihood of Approval

AB-1005 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - AB-1005 in Parkinson's Disease

Data Insights

Carfostin by Asklepios BioPharmaceutical for Congestive Heart Failure (Heart Failure): Likelihood of Approval

Carfostin is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Congestive Heart Failure (Heart Failure). According...

Likelihood of Approval and Phase Transition Success Rate Model - Carfostin in Congestive Heart Failure (Heart Failure)

Data Insights

AB-1005 by Asklepios BioPharmaceutical for Parkinson's Disease: Likelihood of Approval

AB-1005 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...

Data Insights

Carfostin by Asklepios BioPharmaceutical for Congestive Heart Failure (Heart Failure): Likelihood of Approval

Carfostin is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Congestive Heart Failure (Heart Failure). According...

Data Insights

ACTUS-101 by Asklepios BioPharmaceutical for Pompe Disease: Likelihood of Approval

ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - ACTUS-101 in Pompe Disease